• 제목/요약/키워드: Pro-brain natriuretic peptide

검색결과 23건 처리시간 0.016초

경기도 일개 종합병원에서 Pro-Brain Natriuretic Peptide와 통상적 혈액검사 인자간의 상관성 조사 (Study on the Relationship between Pro-Brain Natriuretic Peptide and Routine Blood Test Factors at a General Hospital in Gyeonggi-do)

  • 박동엽;김상수;성현호;박창은
    • 대한임상검사과학회지
    • /
    • 제52권3호
    • /
    • pp.172-180
    • /
    • 2020
  • 본 연구의 목적은 병원정보시스템을 활용하여 N-말단 프로-뇌 나트륨 이뇨 펩타이드(N-terminal pro-brain natriuretic peptide, NT-proBNP)의 결과와 통상적인 혈액검사와의 상관성을 후향적으로 조사하는 것이다. NT-proBNP는 심부전의 병태 생리학에 관여한다. 본 연구결과는 연령과 NT-proBNP의 관계는 양의 상관관계(r=0.163)로 통계적으로 유의하였다(P<0.01). NT-proBNP 농도는 총 단백질(r=-0.250)과 알부민(r=-0.270)은 음의 상관관계, 적혈구수와 혈색소 그리고 적혈구 용적률은 음의 상관관계로 나타난 결과로 나타났다(P<0.01). NT-proBNP는 호중구와 양의 상관관계(r=0.227)와 림프구는 음의 상관관계(r=-0.236)로 통계적으로 유의한 결과가 나타났다(P<0.01). NT-proBNP와 크레아티닌은 양의 상관관계로 나타났으며(r=0.594, P<0.01), 다중회귀분석결과 가장 영향을 미치는 인자로 관찰되었다(B=0.53, t=7.65, P<0.01). NT-proBNP와 요산의 농도는 양의 상관관계로 유의한 관계를 나타냈다(r=0.180, P<0.05). 젖산탈수소효소가 NT-proBNP에 영향을 미치는 인자로 관찰되었다(B=0.20, t=3.28, P<0.01). 이러한 설명력은 43%의 영향력을 나타내어 NT-proBNP의 정확한 검사와 관련인자들은 심장표지자로서 임상적 가치가 있는 것으로 사료된다.

Clinical characteristics and serum N-terminal pro-brain natriuretic peptide as a diagnostic marker of Kawasaki disease in infants younger than 3 months of age

  • Bae, Hyun Kyung;Lee, Do Kyung;Kwon, Jung Hyun;Kim, Hae Soon;Sohn, Sejung;Hong, Young Mi
    • Clinical and Experimental Pediatrics
    • /
    • 제57권8호
    • /
    • pp.357-362
    • /
    • 2014
  • Purpose: The incidence of Kawasaki disease (KD) is rare in young infants (less than 3 months of age), who present with only a few symptoms that fulfill the clinical diagnostic criteria. The diagnosis for KD can therefore be delayed, leading to a high risk of cardiac complications. We examined the clinical characteristics and measured the serum levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) levels of these patients for assessing its value in the early detection of KD. Methods: We retrospectively reviewed the data of young infants diagnosed with KD from 2004 to 2012. The control group included 20 hospitalized febrile patients. Laboratory data, including NT-proBNP were obtained for each patient in both groups. Results: Incomplete KD was observed in 21/24 patients (87.5%). The mean fever duration on admission was $1.36{\pm}1.0$ days in the KD group. Common symptoms included erythema at the site of Bacille Calmette-Guerin inoculation (70.8%), skin rash (50.0%), changes of oropharyngeal mucosa (29.1%), and cervical lymphadenopathy (20.8%). The mean number of major diagnostic criteria fulfilled was $2.8{\pm}1.4$. Five KD patients (20.8%) had only one symptom matching these criteria. The incidence of coronary artery complications was 12.5%. The mean serum NT-proBNP level in the acute phase, in the KD and control groups, were $4,159{\pm}3,714pg/mL$ and $957{\pm}902pg/mL$, respectively, which decreased significantly in the convalescent phase. Conclusion: Incomplete KD was observed in 87.5% patients. Serum NT- proBNP might be a valuable biomarker for the early detection of KD in febrile infants aged <3 months.

Evaluation of plasma N-terminal pro-brain natriuretic peptide and troponin I concentrations in dogs with congenital ventricular outflow tract stenosis

  • Kim, Gye-Dong;Suh, Sang-IL;Park, In-Chul;Hyun, Changbaig
    • 대한수의학회지
    • /
    • 제56권4호
    • /
    • pp.223-227
    • /
    • 2016
  • This study evaluated the levels of cardiac biomarkers in dogs with either pulmonic stenosis or aortic stenosis and the correlation between biomarkers and the severity of stenosis assessed by the echocardiography. To achieve this study goal, 38 dogs (10 healthy control dogs, 15 dogs with pulmonic stenosis and 13 dogs with aortic stenosis) were examined. The jet velocity and pressure gradient in this study population were measured by echocardiographic estimation, after which the study group was subdivided by the severity of stenosis. The plasma cardiac troponin I (cTnI) and N-terminal pro-brain natriuretic peptide (NT-proBNP) were measured in this study group. The median concentrations of cTnI and NT-proBNP of the disease group were significantly higher than those of the control group, and these increased gradually as stenosis worsened. The severity of stenosis and the concentrations of cTnI and NT-porBNP were also found to be significantly correlated. Finally, the plasma cTnI and NT-proBNP tests were found to beneficial for differentiating clinical patients, predicting the progression of disease, and monitoring the outcome of interventional therapy for stenosis.

Differentiation between incomplete Kawasaki disease and secondary hemophagocytic lym­phohistiocytosis following Kawasaki disease using N­-terminal pro­-brain natriuretic peptide

  • Choi, Jung Eun;Kwak, Yujin;Huh, Jung Won;Yoo, Eun-Sun;Ryu, Kyung-Ha;Sohn, Sejung;Hong, Young Mi
    • Clinical and Experimental Pediatrics
    • /
    • 제61권5호
    • /
    • pp.167-173
    • /
    • 2018
  • Purpose: Hemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory syndrome with many causes, including Kawasaki disease (KD). The purpose of this study was to identify the laboratory tests needed to easily differentiate KD with HLH from incomplete KD alone. Methods: We performed a retrospective study on patients diagnosed with incomplete KD and incomplete KD with HLH (HLH-KD) between January 2012 and March 2015. We compared 8 secondary HLH patients who were first diagnosed with incomplete KD with all 247 incomplete KD diagnosed patients during the study period. The complete blood count, erythrocyte sedimentation rate, platelet count, and serum total protein, albumin, triglyceride, C-reactive protein, N-terminal pro-brain natriuretic peptide (NT-proBNP), and ferritin levels were compared. Clinical characteristics and echocardiography findings were also compared between the 2 groups. Results: The total duration of fever was longer in the HLH-KD group than in the KD group. White blood cell and platelet counts were higher in the KD group. Alanine aminotransferase, ferritin, and coronary artery diameter were increased in the HLH-KD group compared with those in the KD group. The median of NT-proBNP was significantly higher in the HLH-KD group than in the KD group at 889.0 (interquartile range [IQR], 384.5-1792.0) pg/mL vs. 233.0 (IQR, 107.0-544.0) pg/mL. Conclusion: The NT-proBNP level may be helpful in distinguishing incomplete KD from KD with HLH. The NT-proBNP level should be determined in KD patients with prolonged fever, in addition to the white blood cell count, platelet count, and ferritin level, to evaluate secondary HLH.

신생아기에 발견된 단독 심실 비치밀화증 1예에서 관찰된 NT pro-BNP의 변화 (Changes in N-terminal pro-B-type natriuretic peptide in a neonate with symptomatic isolated left ventricular noncompaction)

  • 송지현;김여향;김천수;이상락;권태찬
    • Clinical and Experimental Pediatrics
    • /
    • 제52권1호
    • /
    • pp.129-132
    • /
    • 2009
  • 저자들은 청색증과 끙끙거림, 심비대로 전원되어 심장 초음파 검사에서 좌심실에 발생한 단독 심실 비치밀화증을 가진 신생아 1예를 경험하였다. 환자에서 측정한 NT pro-BNP는 높았고, 수유 곤란과 빈호흡을 동반한 심부전 증상이 있었다. 심부전증에 대한 치료에도 불구하고 주기적으로 시행한 NT pro-BNP가 더 높아지면서 환자에게서 급성 심정지가 발생하였고, 심폐소생술 이후 NT pro-BNP가 다시 낮아지면서 심부전 등의 증상은 호전을 보였다. 심초음파 검사와 함께 NT pro-BNP를 주기적으로 검사해 보는 것이 병의 경과를 예측하는데 도움이 될 수 있을 것이다.

Age-adjusted plasma N-terminal pro-brain natriuretic peptide level in Kawasaki disease

  • Jun, Heul;Ko, Kyung Ok;Lim, Jae Woo;Yoon, Jung Min;Lee, Gyung Min;Cheon, Eun Jung
    • Clinical and Experimental Pediatrics
    • /
    • 제59권7호
    • /
    • pp.298-302
    • /
    • 2016
  • Purpose: Recent reports showed that plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) could be a useful biomarker of intravenous immunoglobulin (IVIG) unresponsiveness and coronary artery lesion (CAL) development in Kawasaki disease (KD). The levels of these peptides are critically influenced by age; hence, the normal range and upper limits for infants and children are different. We performed an age-adjusted analysis of plasma NT-proBNP level to validate its clinical use in the diagnosis of KD. Methods: The data of 131 patients with KD were retrospectively analyzed. The patients were divided into 2 groups-group I (high NT-proBNP group) and group II (normal NT-proBNP group)-comprising patients with NT-proBNP concentrations higher and lower than the 95th percentile of the reference value, respectively. We compared the laboratory data, responsiveness to IVIG, and the risk of CAL in both groups. Results: Group I showed significantly higher white blood cell count, absolute neutrophil count, C-reactive protein level, aspartate aminotransferase level, and troponin-I level than group II (P<0.05). The risk of CAL was also significantly higher in group I (odds ratio, 5.78; P=0.012). IVIG unresponsiveness in group I was three times that in group II (odds ratio, 3.35; P= 0.005). Conclusion: Age-adjusted analysis of plasma NT-proBNP level could be helpful in predicting IVIG unresponsiveness and risk of CAL development in patients with KD.

C-reactive protein and N-terminal pro-brain natriuretic peptide discrepancy: a differentiation of adenoviral pharyngoconjunctival fever from Kawasaki disease

  • Choi, Jung Eun;Kang, Hee Won;Hong, Young Mi;Sohn, Sejung
    • Clinical and Experimental Pediatrics
    • /
    • 제61권1호
    • /
    • pp.12-16
    • /
    • 2018
  • Purpose: To differentiate adenoviral pharyngoconjunctival fever (PCF) from acute Kawasaki disease (KD) using laboratory tests before results of virus-real time polymerase chain reaction and ophthalmologic examination are obtained. Methods: Baseline patient characteristics and laboratory measurements were compared between 40 patients with adenovirus infection and 123 patients with KD. Results: The patients with adenovirus infection were generally older than those with KD (median: 3.9 years vs. 2 years, P=0.000). White blood cell and, platelet count, and aspartate aminotransferase, alanine aminotransferase, and N-terminal pro-brain natriuretic peptide (NT-proBNP) levels showed significant differences between the 2 groups, but the C-reactive protein (CRP) levels did not ($6.8{\pm}3.0mg/dL$ vs. $8.3{\pm}5.8mg/dL$, P=0.126). In the adenovirus infection group, the CRP levels were <1, <3, <10, and ${\geq}10mg/dL$ in 2 (5%), 3 (7.5%), 30 (75%), and 5 patients (12.5%), respectively. The cutoff NT-proBNP level was 265 pg/mL. Discrepancy was defined as CRP and NT-proBNP levels of ${\geq}3$ or <3 mg/dL, and <265 or ${\geq}265pg/mL$, respectively. Among the 35 patients with adenovirus infection whose CRP levels were ${\geq}3mg/dL$, 29 (82.9%) showed a discrepancy. Conversely, of the 103 patients with KD whose CRP levels were ${\geq}3mg/dL$, 83 (80.6%) showed no discrepancy. Between the groups, a significant difference in discrepancy rate was observed (P=0.000). None of the patients with adenovirus infection had CRP and NT-proBNP levels of <3 mg/dL and ${\geq}265pg/mL$, respectively. Conclusion: With a sensitivity of 82.9% and a specificity of 80.6%, CRP and NT-proBNP levels may differentiate between adenoviral PCF and acute KD.

폐동맥고혈압 진단에 있어 N-terminal Pro-brain Natriuretic Peptide 측정의 유용성 (The Utility of Measurement of Plasma N-terminal Pro-brain Natriuretic Peptide in Diagnosis of Pulmonary Hypertension)

  • 한창훈;강석민;문진욱;조재희;황상연;이중민;박무석;정재호;김영삼;김세규;장준;심원흠;김성규
    • Tuberculosis and Respiratory Diseases
    • /
    • 제56권1호
    • /
    • pp.67-76
    • /
    • 2004
  • 연구배경 : 만성호흡기질환 환자에서 폐동맥고혈압은 불량한 예후를 나타낸다. 접근성이 용이하고 비침습적인 방법으로서 혈청 NT-proBNP농도 측정이 폐동맥고혈압 진단에 유용성이 있는지 알아보기 위하여 본 연구를 진행하였다. 방 법 : 임상적으로 수축기 폐동맥고혈압이 의심되는 환자 29명을 대상으로 전기화학발광 면역분석법을 이용하여 혈청 NT-proBNP농도를 측정하였고, 동맥혈가스검사, 혈청 생화학검사, 폐기능검사, 그리고 도플러 심초음파검사를 실시하여 우심실 수축기압을 통해 수축기 폐동맥압을 예측하였다. 결 과 : 로그 값으로 치환한 혈청 NT-proBNP농도와 수축기 폐동맥압과는 양성 선형 상관관계를 갖고 있었다(Correlation coefficiency: 0.783, p-value < 0.001). 혈청 NT-proBNP 농도는 우심실 수축기압, 우심실 비대, 심실간 중격의 편평화, 우심실 확장과 유의한 관련이 있었다. 결 론 : 임상적으로 폐동맥고혈압을 의심하는 환자에서 혈청 NT-proBNP 농도 측정은 간단하게 폐동맥고혈압 유무를 알 수 있는 유용한 표지자로서 사용이 가능할 것으로 보이며, 이에 대한 추가 연구가 필요하리라 생각된다.

Pulmonary hypertension in infants with bronchopulmonary dysplasia

  • Kim, Gi-Beom
    • Clinical and Experimental Pediatrics
    • /
    • 제53권6호
    • /
    • pp.688-693
    • /
    • 2010
  • An increase in the number of preterm infants and a decrease in the gestational age at birth have resulted in an increase in the number of patients with significant bronchopulmonary dysplasia (BPD) and secondary pulmonary hypertension (PH). PH contributes significantly to the high morbidity and mortality in the BPD patients. Therefore, regular monitoring for PH by using echocardiography and B-type natriuretic peptide (BNP) or N-terminal-proBNP must be conducted in the BPD patients with greater than moderate degree to prevent PH and to ensure early treatment if PH is present. In the BPD patients with significant PH, multi-modality treatment, including treatment for correcting an underlying disease, oxygen supply, use of diverse selective pulmonary vasodilators (inhaled nitric oxide, inhaled prostacyclins, sildenafil, and endothelin-receptor antagonist) and other methods, is mandatory.

폐동맥고혈압이 동반된 만성폐쇄성폐질환 환자에서 혈중 Brain Natriuretic Peptide, 폐동맥압 및 St. George Respiratory Questionnaire의 상관성과 안지오텐신전환효소억제제 치료 효과 (The Correlation of Brain Natriuretic Peptide (BNP), Pulmonary Arterial Pressure, and St. George Respiratory Questionnaire (SGRQ) and Their Changes with a Trial of an Angiotensin Converting Enzyme Inhibitor)

  • 김명아;김덕겸;이창훈;정희순
    • Tuberculosis and Respiratory Diseases
    • /
    • 제68권5호
    • /
    • pp.273-279
    • /
    • 2010
  • Background: Pulmonary hypertension is considered as a poor prognosis factor in patients with chronic obstructive pulmonary disease (COPD). There has been reported brain natriuretic peptide (pro-BNP) is related with increased right ventricular (RV) workloads. However, there are few studies that evaluate the relationship between BNP and pulmonary arterial pressure (PAP), RV function and St. George Respiratory Questionnaire (SGRQ) score in patients with COPD, and the effects of angiotensin converting enzyme inhibitor (ACEI) on these parameters. Methods: Pulmonary function test, echocardiography, blood BNP, and SGRQ score were evaluated in stabilized moderate degree COPD patients ($FEV_1$/FVC< 70%, $50%{\leq}FEV_1$ < 80%) aged 45 years and over, without worsening of symptoms within recent 3 months. After treating with ramipril 10 mg for 3 months, the same evaluation was repeated. Results: Twenty-two patients were included in this study. BNP was significantly correlated with PAP (Pearson coefficient ${\rho}=0.51$, p=0.02), but not with RV ejection fraction (EF) and predicted $FEV_1%$. The values for predicted $FEV_1%$ showed significant correlation with SGRQ total score and activity score, but not with BNP or PAP. After ramipril treatment, PAP showed significant decrease ($42.8{\pm}8.1$ vs. $34.5{\pm}4.5mm$ Hg p=0.0003), tricuspid annular plane systolic excursion significant increase ($21.5{\pm}3.3$ vs. $22.7{\pm}3.1mm$ p=0.009). BNP showed a tendency to decrease without statistical significance ($40.8{\pm}59.6$ vs. $18.0{\pm}9.1pg/mL$ p=0.55). SGRQ scores showed no significant change. Conclusion: BNP showed significant correlation with resting PAP, which means BNP could be used as markers for pulmonary hypertension. Treatment with ACEI didn't show significant change in the level of BNP, while pulmonary hypertension and RV function were improved.